Metraipolis › archive › dc_976534baedba
Early access disparities in innovative therapies across the US, EU, China, and Japan — Europe PMC PMID:41210884
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41210884
- DOI
- 10.3389/fmed.2025.1642882
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T02:47:27.652Z
- SHA-256 of the archived text
2b157e6b49cdec428684ed16301cd5a3d8e4b8d526a02de9a8f75063cc7ce82e- Stable URL of this page
https://metraipolis.com/documento/dc_976534baedba
How to cite
Early access disparities in innovative therapies across the US, EU, China, and Japan — Europe PMC PMID:41210884 — Europe PMC (en), https://europepmc.org/article/MED/41210884 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_976534baedba (Metraipolis archive dc_976534baedba, sha256 2b157e6b49cdec428684ed16301cd5a3d8e4b8d526a02de9a8f75063cc7ce82e)
BibTeX
@misc{dc976534baedba,
title = {Early access disparities in innovative therapies across the US, EU, China, and Japan — Europe PMC PMID:41210884},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41210884},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_976534baedba; sha256 2b157e6b49cdec428684ed16301cd5a3d8e4b8d526a02de9a8f75063cc7ce82e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41210884. Agents can read the archived copy with the MCP tool read_document.